Antibiotic Use before, during, and after Seeking Care for Acute Febrile Illness at a Hospital Outpatient Department: A Cross-Sectional Study from Rural India.
AWaRe
India
access
acute febrile illness
antibiotic resistance
antibiotic use
antibiotics
excess
fever
low- and middle-income countries
rural population
Journal
Antibiotics (Basel, Switzerland)
ISSN: 2079-6382
Titre abrégé: Antibiotics (Basel)
Pays: Switzerland
ID NLM: 101637404
Informations de publication
Date de publication:
25 Apr 2022
25 Apr 2022
Historique:
received:
31
03
2022
revised:
14
04
2022
accepted:
21
04
2022
entrez:
28
5
2022
pubmed:
29
5
2022
medline:
29
5
2022
Statut:
epublish
Résumé
Antibiotic resistance is a naturally occurring phenomenon, but the misuse and overuse of antibiotics is accelerating the process. This study aimed to quantify and compare antibiotic use before, during, and after seeking outpatient care for acute febrile illness in Ujjain, India. Data were collected through interviews with patients/patient attendants. The prevalence and choice of antibiotics is described by the WHO AWaRe categories and Anatomical Therapeutic Chemical classes, comparing between age groups. Units of measurement include courses, encounters, and Defined Daily Doses (DDDs). The antibiotic prescription during the outpatient visit was also described in relation to the patients' presumptive diagnosis. Of 1000 included patients, 31.1% (
Identifiants
pubmed: 35625218
pii: antibiotics11050574
doi: 10.3390/antibiotics11050574
pmc: PMC9138085
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Swedish Society of Medicine
ID : SLS-776141
Organisme : InDevelops u-landsfond
ID : N/A
Organisme : Uppsala University
ID : N/A
Organisme : Rönnows Foundation travel scholarships
ID : N/A
Références
PLoS One. 2016 Jan 28;11(1):e0146054
pubmed: 26821179
JAC Antimicrob Resist. 2020 Sep;2(3):dlaa048
pubmed: 32974610
Glob Health Res Policy. 2017 May 08;2:14
pubmed: 29202082
Infect Chemother. 2014 Dec;46(4):226-38
pubmed: 25566402
BMJ Glob Health. 2020 Sep;5(9):
pubmed: 32938614
BMJ Open. 2020 Nov 26;10(11):e041087
pubmed: 33243808
PLoS Med. 2015 May 12;12(5):e1001826; discussion e1001826
pubmed: 25965416
PLoS One. 2019 Aug 1;14(8):e0220316
pubmed: 31369610
Antibiotics (Basel). 2019 Sep 05;8(3):
pubmed: 31491900
Nat Microbiol. 2019 Jan;4(1):46-54
pubmed: 30546093
Clin Microbiol Infect. 2021 Sep;27(9):1293-1300
pubmed: 33188934
Nat Med. 2019 Sep;25(9):1370-1376
pubmed: 31406349
Clin Infect Dis. 2020 Dec 1;71(Suppl 3):S285-S292
pubmed: 33258935
J Pediatr. 2020 May;220:125-131.e5
pubmed: 32093934
BMC Infect Dis. 2020 May 13;20(1):340
pubmed: 32404055
Pharm Pract (Granada). 2021 Jan-Mar;19(1):2206
pubmed: 33828621
Br J Clin Pharmacol. 2019 Jan;85(1):59-70
pubmed: 29397576
Indian J Med Res. 2019 Feb;149(2):87-96
pubmed: 31219073
Clin Infect Dis. 2018 May 2;66(10):1602-1609
pubmed: 29211830
Health Policy. 2004 May;68(2):211-22
pubmed: 15063020
PLoS One. 2021 Jan 20;16(1):e0241899
pubmed: 33471786
Int J Infect Dis. 2020 Jul;96:334-342
pubmed: 32437937
Scand J Infect Dis. 2011 Jul;43(6-7):479-88
pubmed: 21299365
J Perinatol. 2016 Dec;36(s3):S9-S12
pubmed: 27924110
Rev Environ Contam Toxicol. 2007;191:131-62
pubmed: 17708074
Indian J Med Res. 2011 Nov;134(5):627-38
pubmed: 22199101
Antimicrob Agents Chemother. 2006 Nov;50(11):3646-50
pubmed: 16940064
Lancet Infect Dis. 2019 Jan;19(1):67-75
pubmed: 30522834
PLoS Med. 2016 Mar 02;13(3):e1001974
pubmed: 26934098
BMJ. 2021 Feb 26;372:n437
pubmed: 33637488